Intelligent cardiovascular stent

The technology involves a stent that incorporates a sensor, which with further development, will be capable of continuously monitoring in-stent restenosis, and transmitting this data to a device outside the body. In a practical application, the stent is likely to be interrogated by a cardiologist at appropriate intervals during a clinical consultation. The key is adaption of the sensor for implantation in a stent. Currently our sensor systems have been developed to monitor pertinent parameters using an in vitro model of restenosis.

Key Benefits

In situ monitoring of restinosis
Continuous in-stent monitoring
Self-reporting
Non-invasive, no catheterisation required
Earlier treatment of the condition

Applications

The worldwide coronary stent market was over US$5 billion in 2005 and was forecast to have reached US$6 billion in 2006. The opportunity for an intelligent stent with built in restinosis monitoring/reporting functionality is therefore considerable.

IP Status

Contact is welcomed from organisations interested in developing, licensing or exploiting this technology. The University of Strathclyde is securing patent
protection for the technology.

If you would like further information about this opportunity please fill out the form below. Your enquiry will be passed on to the relevant University who will respond to you directly.

OPPORTUNITY	Intelligent cardiovascular stent
NAME*
COMPANY NAME
COUNTRY
EMAIL*
TELEPHONE
	* denotes compulsory field

If you register you will receive automatic email notification of technologies in the sectors you indicate. Filling on the form takes only a few minutes and will ensure you are kept up to date with new additions to the university-technology website.